Experimental drug karonudib tested in patients with no other options
NCT ID NCT04077307
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 26 times
Summary
This early-phase study tests the safety and tolerability of a new drug called Karonudib in adults with blood cancers like leukemia who have exhausted standard treatments. The goal is to find a safe dose and look for early signs that the drug might help control the disease. Only 9 participants will be enrolled.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEUKEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Aarhus University Hospital
RECRUITINGAarhus, Denmark
Contact
-
Karolinska University Hospital
RECRUITINGHuddinge, Sweden
Contact
Contact
-
Rigshospitalet Copenhagen University Hospital
RECRUITINGCopenhagen, Denmark
Contact
-
University Clinical Center Belgrade
RECRUITINGBelgrade, Serbia
Contact
-
University Clinical Center Kragujevac
RECRUITINGKragujevac, Serbia
Contact
-
Örebro University Hospital
RECRUITINGÖrebro, Sweden
Contact
Conditions
Explore the condition pages connected to this study.